Clinical study on the combined use of cardiovascular agents and statins in the treatment of coronary heart disease
Zhili Chen, Qianqian Zhang, Yue Zhang, Zhe Xu, Xiaozhe Yang · 2026
Read Clinical study on the combined use of cardiovascular agents and statins in the treatment of coronary heart disease by Zhili Chen, Qianqian Zhang, Yue Zhang, Zhe Xu, Xiaozhe Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624433.txt.
Description
Zhili Chen and co-authors test adding a statin to standard heart care in 2026. Coronary heart disease narrows the arteries that feed the heart. Standard care already joins blood thinners, vessel openers, and anti angina drugs. The question is what a statin adds on top of that base.
Records came from over a hundred patients at one Chinese hospital. Half got standard care alone, and half got a statin added. The team compared response rates, blood fats, inflammation markers, and chest pain episodes. Side effects were tracked as well. The added statin arm reported a higher overall response rate in the study.
Catalog record
| CREATOR | Zhili Chen, Qianqian Zhang, Yue Zhang, Zhe Xu, Xiaozhe Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |